Ivanova, Jasmina I.; Birnbaum, Howard G.; Kidolezi, Yohanne - In: PharmacoEconomics 28 (2010) 8, pp. 675-685
Background: The direct cost burden of epilepsy in the US from a third-party payer perspective has not been evaluated. Furthermore, no study has quantified the indirect (work-loss) cost burden of epilepsy from an employer perspective in the US. Objective: To assess the annual direct costs for...